Benzyl Dimethylcarbamate

Benzyl Dimethylcarbamate

SCHEMBL5134244

CN(C)C(=O)OCc1ccccc1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.62
MAPT P10636 1/20 0.56
HPGD P15428 1/20 0.56
MAPK1 P28482 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A3 Q01959 1/20 0.55
KMT2A Q03164 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
CHRNB2 P17787 1/20 0.50
CHRNB4 P30926 1/20 0.50
CHRNA3 P32297 1/20 0.50
CHRNA4 P43681 1/20 0.50
LMNA P02545 1/20 0.50
SIGMAR1 Q99720 1/20 0.50
ABCB1 P08183 1/20 0.50
HCAR2 Q8TDS4 1/20 0.50
CCR6 P51684 1/20 0.49
PAX8 Q06710 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzyl Dimethylcarbamate SCHEMBL20401678 1.00 ALDH1A1 (0.62) ALDH1A1MAPTHPGDMAPK1L3MBTL1
Benzyl Dimethylcarbamate SCHEMBL14031385 1.00 ALDH1A1 (0.62) ALDH1A1MAPTHPGDMAPK1L3MBTL1
SCHEMBL7694634 0.90 PRSS1 (0.47) ALDH1A1MAPTHPGDMAPK1L3MBTL1
SCHEMBL4435505 0.88 ALOX5 (0.64) L3MBTL1SLC6A2SLC6A3LMNA
SCHEMBL7694380 0.88 ALDH1A1 (0.62) ALDH1A1MAPTHPGDMAPK1L3MBTL1
SCHEMBL21297533 0.88 ALDH1A1 (0.56) ALDH1A1MAPTHPGDMAPK1L3MBTL1
SCHEMBL250619 0.86 ALDH1A1 (0.60) ALDH1A1MAPTHPGDMAPK1L3MBTL1
SCHEMBL24968118 0.85 ALDH1A1 (0.58) ALDH1A1MAPTHPGDMAPK1L3MBTL1
SCHEMBL24115182 0.85 ALDH1A1 (0.58) ALDH1A1MAPTHPGDMAPK1L3MBTL1
SCHEMBL8016043 0.85 ALDH1A1 (0.58) ALDH1A1MAPTHPGDMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6043254-A ANTIPROLIFERATIVE AGENT; ENZYME INHIBITOR BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-03-28 US claimed
US-20240360179-A1 STAPLED PEPTIDES AND METHODS THEREOF PARABILIS MEDICINES, INC. 2024-10-31 US disclosed
US-20240116985-A1 STAPLED PEPTIDES AND METHODS THEREOF PARABILIS MEDICINES, INC. 2024-04-11 US disclosed
CN-117396469-A Inhibitors of plasma kallikrein 武田药品工业株式会社 2024-01-12 CN disclosed
WO-2023178299-A1 PRODRUGS OF GANAXOLONE MARINUS PHARMACEUTICALS, INC. (US) 2023-09-21 WO disclosed
US-11691969-B2 Pyridazinones as PARP7 inhibtors RIBON THERAPEUTICS, INC. (US) 2023-07-04 US disclosed
EP-3362445-B1 OXADIAZOLE AMINE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2023-01-25 EP disclosed
WO-2022109117-A1 3-AMINO PYRROLIDINE AND PIPERIDINE MACROCYCLIC OREXIN RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2022-05-27 WO disclosed
EP-3912974-A1 TRIAZOLE COMPOUNDS, AND PREPARATION METHOD THEREOF AND USE Wuhan LL Science And Technology Development Co., Ltd. (CN) 2021-11-24 EP disclosed
EP-3858439-A1 AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2021-08-04 EP disclosed
WO-2008118167-A1 METHOD FOR FORMING MOLECULAR SEQUENCES ON SURFACES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-10-02 WO disclosed
US-7405212-B2 Helix mimetics and composition and methods related thereto MYRIAD GENETICS, INC. (US) 2008-07-29 US disclosed
US-7405212-B2 Helix mimetics and composition and methods related thereto MYRIAD GENETICS, INC. (US) 2008-07-29 US disclosed
US-20080027093-A1 Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes MERCK SHARP & DOHME LLC 2008-01-31 US disclosed
US-20070244158-A1 Piperdine Compound and Process for Preparing the Same MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-10-18 US disclosed
US-20070224616-A1 METHOD FOR FORMING MOLECULAR SEQUENCES ON SURFACES NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2007-09-27 US disclosed
CN-1871226-A Dihydrobenzofuranalkylamines and pharmaceutical compositions containing them WYETH CORP (US) 2006-11-29 CN disclosed
EP-1537112-A1 CONDENSED PYRIDINES AND PYRIMIDINES WITH TIE2 (TEK) ACTIVITY Astrazeneca AB (SE) 2005-06-08 EP disclosed
WO-2004013141-A1 CONDENSED PYRIDINES AND PYRIMIDINES WITH TIE2 (TEK) ACTIVITY ASTRAZENECA AB (SE) 2004-02-12 WO disclosed
US-6043254-A ANTIPROLIFERATIVE AGENT; ENZYME INHIBITOR BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116985-A1 STAPLED PEPTIDES AND METHODS THEREOF CTNNB1, APC, CTNNA1 ALDH1A1 4142/4885MAPT 2476/4885HPGD 4500/4885
US-20080027093-A1 Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes DPP4, DPP3, DPP7 ALDH1A1 1691/4885MAPT 3094/4885HPGD 1456/4885
US-20070244158-A1 Piperdine Compound and Process for Preparing the Same AVPR1B, PRLHR, HRH4 ALDH1A1 2744/4885MAPT 4291/4885HPGD 1586/4885
US-20240360179-A1 STAPLED PEPTIDES AND METHODS THEREOF CTNNB1, APC, CTNNA1 ALDH1A1 4055/4885MAPT 2642/4885HPGD 4357/4885
US-11691969-B2 Pyridazinones as PARP7 inhibtors PARP2, PARP1, PARP4 ALDH1A1 358/4885MAPT 2875/4885HPGD 471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.